预后算法用于肝硬化和ACLF急性失补偿
Shantha R Valainathan1,2,3, Qing Xie4, Vicente Arroyo5
1Université Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR 1149, Paris, France.
概括
预测肝硬化患者的存活率,特别是急性至慢性肝衰竭患者 (ACLF) 的存活率至关重要. 目前的得分可以改善决策,但需要用生物标志物来提高,以便更好地预测死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 医学统计 医学统计
背景情况:
- 在肝硬化中准确的生存预测对于及时的肝移植和治疗干预是必不可少的.
- 急性至慢性肝衰竭 (ACLF) 是一个具有高短期死亡率的关键子组.
- 现有的肝硬化严重性评分 (Child-Pugh,MELD) 并不能完全捕捉到ACLF的复杂性.
研究的目的:
- 审查和比较现有的评分系统,以检测肝硬化和ACLF的急性脱补偿.
- 讨论这些分数的验证,局限性和潜在的改进.
- 突出需要新型得分,包括生物标志物,以提高预测准确度.
主要方法:
- 已建立和最近开发的肝硬化和ACLF评分系统 (Clif-C-AD,Clif-C-ACLF,AARC,NASCELD-ACLF) 的审查.
- 对得分组件的分析,包括器官衰竭和全身炎症.
- 讨论验证数据和预测性能 (ROC曲线下的区域).
主要成果:
- 专门的分数,如Clif-C-AD已经开发和验证了急性脱补偿.
- 对ACLF存在多个分数 (Clif-C-ACLF,AARC,NASCELD-ACLF),显示了国际采用.
- 当前的得分虽然提高了统一性和决策,但具有预测限制 (AUC < 0.8).
结论:
- 现有的得分代表了治疗肝硬化和ACLF的重大进步.
- 为了获得更好的患者结果,需要不断完善预后模型.
- 结合反映肝硬化病理生理学的新生物标志物是改善死亡率预测的有希望的途径.
相关概念视频
01:24Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
01:29Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86